Efficacy News and Research

RSS
Novo Solutions MD announces releases of NovoScarMD scar cream

Novo Solutions MD announces releases of NovoScarMD scar cream

Studies support use of EOS 3D imaging system in assessing impact of bracing for AIS

Studies support use of EOS 3D imaging system in assessing impact of bracing for AIS

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

Innovative microsurgery technique helps prevent lymphedema in patients with breast cancer

Innovative microsurgery technique helps prevent lymphedema in patients with breast cancer

OracleBio to highlight Oncology image analysis expertise at Tumor Models conference

OracleBio to highlight Oncology image analysis expertise at Tumor Models conference

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

New procedures to improve quality and usefulness of preclinical efficacy studies

New procedures to improve quality and usefulness of preclinical efficacy studies

Prana Biotechnology completes PBT2 phase 2 trial in patients with Huntington's disease

Prana Biotechnology completes PBT2 phase 2 trial in patients with Huntington's disease

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Improving vaccination rates in boys plays a crucial role against HPV infection

Improving vaccination rates in boys plays a crucial role against HPV infection

Chinese herbal medicine appears to be an effective treatment for vascular dementia

Chinese herbal medicine appears to be an effective treatment for vascular dementia

Imprimis to begin IRB-approved Impracor Phase III trial for acute pain associated with OA of the knee

Imprimis to begin IRB-approved Impracor Phase III trial for acute pain associated with OA of the knee

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research

Ligand, Azure Biotech sign global license agreement for development of lasofoxifene

Ligand, Azure Biotech sign global license agreement for development of lasofoxifene

Great Lakes NeuroTechnologies receives patent for Parkinson’s disease monitoring technology

Great Lakes NeuroTechnologies receives patent for Parkinson’s disease monitoring technology

BioCryst completes BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

BioCryst completes BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

Teduglutide offers relief for patients with short-bowel syndrome

Teduglutide offers relief for patients with short-bowel syndrome

Phase 2 EORTC trial shows moderate dose radiotherapy is effective in desmoid-type fibromatosis patients

Phase 2 EORTC trial shows moderate dose radiotherapy is effective in desmoid-type fibromatosis patients

American Crystallographic Association analysis may help researchers design vaccine against HIV/AIDS

American Crystallographic Association analysis may help researchers design vaccine against HIV/AIDS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.